Clinical Trials
725 trialsGC-CCP
RAND
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
Impact of Education Methods on HPV Knowledge and Screening Behavior
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
University of California, Los Angeles
NOVEL
Imperial College London
The Effect of Vaginal Dilator Use
Istanbul Aydın University
RIDECA
University Hospital, Montpellier
BEATcc
Grupo Español de Investigación en Cáncer de Ovario
Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal
Kathmandu University School of Medical Sciences
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Montefiore Medical Center
LETSGO
Sorlandet Hospital HF
VESICOL
Institut de Cancérologie de Lorraine
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Fox Chase Cancer Center
GYNCOG
Northwestern University
KETOCOL
Centre Oscar Lambret
MK-4700-001
Merck Sharp & Dohme LLC
ROBO-GYN
Centre Oscar Lambret
TEP-Curie
Centre Oscar Lambret
Mobile App-Supported HPV and Breast Cancer Awareness Program
Ataturk University
SKYSCRAPER-04
Hoffmann-La Roche
Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer
Sun Yat-sen University
LYSA
University College Cork
NELCER
Tata Memorial Hospital
innovaTV 301
Seagen Inc.
COMBAT-Cx
Tata Memorial Hospital
KEYNOTE-A18
Merck Sharp & Dohme LLC
ACT2
UNC Lineberger Comprehensive Cancer Center
PROP-CC
Saveetha University
PARCER
Tata Memorial Hospital
PaCUDAHL-Gé
University Hospital, Lille
KEYNOTE-826
Merck Sharp & Dohme LLC
FORTITUDE-301
Amgen
The Effect of Motivational Interviewing on HPV-DNA Testing
Istanbul University - Cerrahpasa
Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer
Xinqiao Hospital of Chongqing
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Radiation Therapy Oncology Group
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
Risen (Suzhou) Pharma Tech Co., Ltd.
APACHE-3
University Hospital, Tours
SENTICOL2
Hospices Civils de Lyon
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
Sichuan Cancer Hospital and Research Institute
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
CRISPR Therapeutics
CETUXICOL
Institut Curie
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Laekna Limited
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
National Cancer Institute (NCI)
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer
University of Southern California
AYAConnect
UNC Lineberger Comprehensive Cancer Center
The Femscope Calm Collect Device
University of Michigan
Gynecologic Brachytherapy-Specific Educational Video
University of California, San Diego
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
New Mexico Cancer Research Alliance